Mushfiquddin Khan Selected Research

Mushfiquddin Khan Research Topics

Disease

13	Stroke (Strokes) 01/2020 - 05/2004
12	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 06/2004
10	Brain Ischemia (Cerebral Ischemia) 01/2020 - 05/2003
10	Inflammation (Inflammations) 08/2015 - 05/2004
8	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2015 - 12/2003
6	Infarction (Infarctions) 01/2020 - 05/2003
6	Ischemia 01/2020 - 05/2003
6	Body Weight (Weight, Body) 12/2019 - 08/2006
6	Demyelinating Diseases (Demyelinating Disease) 03/2013 - 06/2004
4	Neuroinflammatory Diseases 01/2022 - 06/2004
4	Contusions 01/2022 - 08/2015
4	Pain (Aches) 01/2022 - 03/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 10/2004
4	Multiple Sclerosis 11/2021 - 09/2005
4	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2017 - 11/2009
3	Metabolic Diseases (Metabolic Disease) 04/2013 - 01/2009
2	Hypoxia (Hypoxemia) 01/2021 - 05/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2021
2	Cognitive Dysfunction 01/2020 - 08/2008
2	Brain Injuries (Brain Injury) 01/2019 - 11/2009
2	Wounds and Injuries (Trauma) 07/2015 - 11/2009
2	Transient Ischemic Attack 01/2015 - 01/2012
2	Edema (Dropsy) 11/2012 - 07/2011
2	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2008 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 05/2008 - 08/2004
2	Ischemic Stroke 07/2007 - 09/2006
2	Reperfusion Injury 05/2004 - 05/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Brain Infarction 01/2020
1	Amyloidosis 01/2020
1	Atrophy 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Sepsis (Septicemia) 10/2016
1	Pathologic Constriction (Stenosis) 05/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015

Drug/Important Bio-Agent (IBA)

16	S-NitrosoglutathioneIBA 01/2021 - 02/2005
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2004
6	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020 - 07/2011
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2008
5	Pharmaceutical PreparationsIBA 01/2020 - 07/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 12/2003
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2009 - 05/2003
4	N6022IBA 01/2021 - 12/2019
4	CytokinesIBA 01/2021 - 08/2004
4	Glutathione (Reduced Glutathione)IBA 01/2015 - 05/2003
4	AntioxidantsIBA 07/2007 - 05/2003
3	AldehydesIBA 01/2022 - 07/2011
3	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 12/2019
3	LipopolysaccharidesIBA 10/2016 - 02/2004
3	LipidsIBA 05/2015 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 09/2012
3	Lovastatin (Mevacor)FDA LinkGeneric 08/2008 - 10/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 10/2004
2	Membrane LipidsIBA 01/2022 - 08/2009
2	EnzymesIBA 01/2022 - 01/2020
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 02/2005
2	LeukotrienesIBA 05/2015 - 05/2006
2	caffeic acid phenethyl esterIBA 04/2013 - 07/2007
2	salicylhydroxamic acid (SHAM)IBA 03/2013 - 07/2011
2	Simvastatin (Zocor)FDA LinkGeneric 03/2013 - 04/2010
2	Histone Deacetylase InhibitorsIBA 01/2013 - 11/2011
2	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 07/2011
2	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 11/2011 - 01/2009
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 07/2010 - 05/2006
2	Secretory Phospholipases A2IBA 08/2009 - 06/2008
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2008 - 07/2007
2	Psychosine (Galactosylsphingosine)IBA 06/2008 - 06/2005
2	Amyloid beta-PeptidesIBA 05/2008 - 08/2004
2	NF-kappa B (NF-kB)IBA 07/2007 - 05/2006
2	Free RadicalsIBA 06/2005 - 05/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004 - 05/2003
2	Interferon-gamma (Interferon, gamma)IBA 06/2004 - 02/2004
1	N- (1,3- benzodioxol- 5- ylmethyl)- 2,6- dichlorobenzamideIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Pertussis ToxinIBA 11/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2021
1	Mitochondrial Aldehyde DehydrogenaseIBA 01/2021
1	glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2019
1	CalpainIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016
1	Caspase 3 (Caspase-3)IBA 10/2016
1	CalciumIBA 07/2015
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2015
1	Phospholipases A2 (Phospholipase A2)IBA 05/2015
1	Dinoprostone (PGE2)FDA Link 05/2015
1	Nonesterified Fatty Acids (NEFA)IBA 05/2015
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 05/2015
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Leukotriene B4IBA 05/2015

Therapy/Procedure

14	Therapeutics 01/2021 - 12/2003
1	Immunomodulation 01/2021
1	Oral Administration 08/2015